How Much Did Medeloop Raise?
Funding & Key Investors

Medeloop, a medtech innovator, has secured significant enterprise-level funding, with its total funding reaching $23.5M. The company recently announced a major strategic investment of $15.5M, underscoring its pivotal role in advancing clinical research and trials through AI-driven solutions. This latest capital infusion signals a new phase of growth and development for the Palo Alto-based firm.

What is Medeloop?

Medeloop
SoftwareHealthcare Software

Medeloop is at the forefront of medical technology, offering a comprehensive, AI-driven platform designed to streamline the execution of early-stage clinical research and clinical trials. By leveraging artificial intelligence, the company aims to enhance the efficiency, accuracy, and speed of critical research processes, thereby accelerating the development of new medical treatments and therapies. The company's innovative approach addresses key challenges in the clinical trial landscape, positioning it as a key player in the medtech sector.

How much funding has Medeloop raised?

Medeloop has raised a total of $23.5M across 2 funding rounds:

2023

Angel/Seed

$8M

2024

Series A

$15.5M

Angel/Seed (2023): $8M with participation from Maven Ventures and General Catalyst

Series A (2024): $15.5M led by General Catalyst, Inovia, Maven Ventures, and Icon Ventures

Key Investors in Medeloop

General Catalyst

General Catalyst is a venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors and stages, known for backing ambitious visions that reshape industries.

Inovia

iNovia Capital is a full-stack venture firm that partners with founders to build enduring global technology companies, with a focus on investing in people first.

Maven Ventures

Maven Ventures is a leading seed-stage venture capital fund investing in software startups with the potential to build billion-dollar businesses that improve the world.

What's next for Medeloop?

With the recent influx of major strategic investment, Medeloop is poised for significant expansion and technological advancement. The capital is expected to fuel further development of its AI platform, enhance its market reach, and potentially broaden its service offerings within the clinical research ecosystem. This funding round, characterized as enterprise-level, suggests Medeloop is moving towards scaling its operations and solidifying its position as a leader in AI-powered clinical trial solutions. The company's trajectory indicates a strong focus on innovation and market penetration in the competitive medtech industry.

See full Medeloop company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftware
Engineering SoftwareSoftwareSecurity Software
Engineering SoftwareSoftware
Customer Engagement PlatformsSoftware

Frequently Asked Questions Regarding Medeloop Financial Insights

What are the most recent funding rounds that Medeloop has completed, and what were the funding rounds?
Medeloop has recently completed 2 funding rounds: Series A on Nov 13, 2024, Angel/Seed on Sep 21, 2023.
What is the total amount of funding Medeloop has raised to date?
Medeloop has raised a total of $23.5M in funding to date.
How many funding rounds has Medeloop completed?
Medeloop has completed 2 funding rounds.
How much funding did Medeloop raise in its most recent funding round?
Medeloop raised $15.5M in its most recent funding round.
Who are the lead investors in Medeloop's latest funding round?
The lead investor in Medeloop's latest funding round was General Catalyst. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Medeloop's history?
The largest funding round in Medeloop's history was $15.5M.
See more information about Medeloop